Literature DB >> 10736753

Mechanisms of nuclear translocation of insulin.

S Harada1, R M Smith, L Jarett.   

Abstract

Insulin (Ins) and various other hormones and growth factors have been shown to be rapidly internalized and translocated to the cell nucleus. This review summarizes the mechanisms that are involved in the translocation of Ins to the nucleus, and discusses its possible role in Ins action, based on observations by the authors and others. Ins is internalized to endosomes by both receptor-mediated and fluid-phase endocytosis, the latter occurring only at high Ins concentrations. The authors recently demonstrated the caveolae are the primary cell membrane locations responsible for initiating the signal transduction cascade induced by Ins. Once Ins is internalized, Ins dissociates from the Ins receptor in the endosome, and is translocated to the cytoplasm, where most Ins is degraded by Ins-degrading enzyme (IDE), although how the polypeptides cross the lipid bilayer is unknown. Some Ins escapes the degradation and binds to cytosolic Ins-binding proteins (CIBPs), in addition to IDE. IDE and some CIBPs are known to be binding proteins for other hormones or their receptors, and are involved in gene regulation, suggesting physiological relevance of CIBPs in the signaling of Ins and other hormones. Ins is eventually translocated through the nuclear pore to the nucleus, where Ins tightly associates with nuclear matrix. The role of Ins internalization and translocation to the nucleus is still controversial, although there is substantial evidence to support its role in cellular responses caused by Ins. Many studies indicate that nuclear translocation of various growth factors and hormones plays an important role in cell proliferation or DNA synthesis. It would be reasonable to suggest that Ins internalization, its association with CIBPs, and its translocation to the nucleus may be essential for the regulation of nuclear events by Ins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10736753     DOI: 10.1007/BF02738245

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  9 in total

1.  Insulin capture by an insulin-linked polymorphic region G-quadruplex DNA oligonucleotide.

Authors:  Adam C Connor; Kimberley A Frederick; Elizabeth J Morgan; Linda B McGown
Journal:  J Am Chem Soc       Date:  2006-04-19       Impact factor: 15.419

2.  Effect of dexamethasone and testosterone treatment on the regulation of insulin-degrading enzyme and cellular changes in ventral rat prostate after castration.

Authors:  Juliany S B César Vieira; Karina L A Saraiva; Maria C L Barbosa; Regina C C Porto; Juan C Cresto; Christina A Peixoto; Maria I Wanderley; Daniel P Udrisar
Journal:  Int J Exp Pathol       Date:  2011-04-21       Impact factor: 1.925

Review 3.  Co-option of endocytic functions of cellular caveolae by pathogens.

Authors:  J S Shin; S N Abraham
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

4.  Receptor binding characteristics and cytotoxicity of insulin-methotrexate.

Authors:  Xiao-Hong Ou; An-Ren Kuang; Zheng-Lu Liang; Xian Peng; Yu-Guo Zhong
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 5.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

6.  Direct recruitment of insulin receptor and ERK signaling cascade to insulin-inducible gene loci.

Authors:  Joel D Nelson; Renée C LeBoeuf; Karol Bomsztyk
Journal:  Diabetes       Date:  2010-10-07       Impact factor: 9.461

Review 7.  Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.

Authors:  Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Biomedicines       Date:  2021-01-17

8.  Insulin-Degrading Enzyme: Paradoxes and Possibilities.

Authors:  Malcolm A Leissring
Journal:  Cells       Date:  2021-09-16       Impact factor: 6.600

9.  Designed Functional Dispersion for Insulin Protection from Pepsin Degradation and Skeletal Muscle Cell Proliferation: In Silico and In Vitro Study.

Authors:  Veera C S R Chittepu; Poonam Kalhotra; Tzayhri Gallardo-Velázquez; Raúl René Robles-de la Torre; Guillermo Osorio-Revilla
Journal:  Nanomaterials (Basel)       Date:  2018-10-19       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.